afm-13
affimed
['redirect study', 'afm13', 'lymphoma', 'afm13 ', '$afmd']
$afmd presents final data demonstrating safety and efficacy of afm13 phase 2 redirect study in patients with heavily pretreated relapsed or refractory peripheral t cell lymphoma at #aacr23 
Investor/trader focused primarily in the biopharma sector. 
Tweets are not investment advice and are not recommendations of any kind.